JP Morgan Private Wealth Advisors’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$466K Buy
20,247
+35
+0.2% +$890 ﹤0.01% 1275
2023
Q2
$528K Sell
20,212
-115
-0.6% -$3.04K ﹤0.01% 1008
2023
Q1
$561K Sell
20,327
-89
-0.4% -$2.35K ﹤0.01% 1428
2022
Q4
$464K Sell
20,416
-1,461
-7% -$40.7K ﹤0.01% 1499
2022
Q3
$745K Buy
21,877
+555
+3% +$20.5K ﹤0.01% 1281
2022
Q2
$621K Buy
+21,322
New +$542K ﹤0.01% 1369

Other funds holding PRVA

JP Morgan Private Wealth Advisors's PRVA Position: Q3 2023 in Review

JP Morgan Private Wealth Advisors increased its Privia Health (PRVA) stake by 0.17% in Q3 2023, buying an estimated $890 and bringing the position to 20,247 shares worth $466K. The position accounts for ﹤0.01% of the portfolio, ranked #1275.

JP Morgan Private Wealth Advisors first reported a position in PRVA in Q2 2022 and has held it in 6 quarters since. The position peaked at $745K in Q3 2022. 218 funds tracked by Wall St. Rank hold PRVA as of Q3 2023.

  • JP Morgan Private Wealth Advisors held 20,247 shares of Privia Health worth $466K as of Q3 2023.
  • JP Morgan Private Wealth Advisors bought 35 Privia Health shares in Q3 2023, an estimated $890.
  • Privia Health made up ﹤0.01% of JP Morgan Private Wealth Advisors's portfolio in Q3 2023, its #1275 holding.
  • JP Morgan Private Wealth Advisors first reported a position in Privia Health in Q2 2022 and has held it in 6 quarters since.
  • JP Morgan Private Wealth Advisors's Privia Health position peaked at $745K in Q3 2022.
  • 218 funds tracked by Wall St. Rank held Privia Health as of Q3 2023.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.